These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 11132390

  • 1. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
    Mayo RE, Stanford JL.
    Trans R Soc Trop Med Hyg; 2000; 94(5):563-8. PubMed ID: 11132390
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC, Abdulmumini T, Robinson S, Rook GA, Stanford JL.
    Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul 10; 354(9173):116-9. PubMed ID: 10408487
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J, Stanford C, Grange J.
    Front Biosci; 2004 May 01; 9():1701-19. PubMed ID: 14977580
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ.
    J Infect Dis; 2000 Apr 01; 181(4):1304-12. PubMed ID: 10753731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis.
    Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A.
    Int J Tuberc Lung Dis; 2004 Nov 01; 8(11):1348-54. PubMed ID: 15581204
    [Abstract] [Full Text] [Related]

  • 12. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B, Garner P.
    Cochrane Database Syst Rev; 2001 Nov 01; (1):CD001166. PubMed ID: 11279709
    [Abstract] [Full Text] [Related]

  • 13. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
    Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP.
    Thorax; 2008 Jul 01; 63(7):627-34. PubMed ID: 18250184
    [Abstract] [Full Text] [Related]

  • 14. Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.
    von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, Matee M, Bakari M, Tvaroha S, Adams LV, Horsburgh CR, Pallangyo K, DarDar Study Group.
    AIDS; 2010 Mar 13; 24(5):675-85. PubMed ID: 20118767
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.